[{"NetIncomeLoss_1_Q1_USD":-200291000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_1_Q1_USD":6847000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":280527000.0,"InventoryFinishedGoods_0_Q1_USD":13753000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-36717000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":71352000.0,"DepreciationAmortizationAndAccretionNet_1_Q1_USD":12601000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":75000.0,"PaymentsForProceedsFromOtherInvestingActivities_1_Q1_USD":4198000.0,"AssetsCurrent_0_Q1_USD":2470083000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":117080000.0,"LongTermDebt_0_Q1_USD":191590000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_1_Q1_USD":345954000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":146859000.0,"ContractWithCustomerLiability_0_Q1_USD":94759000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":23023000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":15397000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":47034000.0,"EquitySecuritiesFvNi_0_Q1_USD":56967000.0,"CommonStockSharesIssued_0_Q1_shares":117321000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":1273027000.0,"Assets_0_Q1_USD":3255269000.0,"ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_1_Q1_USD":-58000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":6905000.0,"EquitySecuritiesFvNiGainLoss_1_Q1_USD":47016000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":-1000.0,"InventoryRawMaterials_0_Q1_USD":53694000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":-3910000.0,"RestrictedInvestmentsNoncurrent_0_Q1_USD":40725000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":19044000.0,"AccountsReceivableNetCurrent_0_Q1_USD":110626000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":1016000.0,"CommonStockValue_0_Q1_USD":1173000.0,"StockIssuedDuringPeriodValueShareBasedCompensationGross_1_Q1_USD":0.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":-66573000.0,"DebtInstrumentInterestRateStatedPercentage_0_Q1_pure":0.15,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":51177000.0,"RestrictedCash_0_Q1_USD":2462000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_1_Q1_USD":438682000.0,"IncreaseDecreaseInInventories_1_Q1_USD":-1934000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-193386000.0,"OtherAssetsNoncurrent_0_Q1_USD":42676000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":379543000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":288015000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":5747394000.0,"Liabilities_0_Q1_USD":2329079000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_1_Q1_USD":46977000.0,"CostsAndExpenses_1_Q1_USD":363820000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":185899000.0,"ShareBasedCompensation_1_Q1_USD":55690000.0,"ProceedsFromDerivativeInstrumentFinancingActivities_1_Q1_USD":4200000.0,"CommonStockSharesOutstanding_0_Q1_shares":117321000.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q1_USD":25300000.0,"PaymentsToAcquireRestrictedInvestments_1_Q1_USD":10650000.0,"OtherOperatingActivitiesCashFlowStatement_1_Q1_USD":30777000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":422000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-199275000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":56295000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-235660000.0,"InventoryWorkInProcess_0_Q1_USD":23593000.0,"LiabilitiesCurrent_0_Q1_USD":494825000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":10709000.0,"OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_1_Q1_USD":-58000.0,"NonoperatingIncomeExpense_1_Q1_USD":-13021000.0,"InterestExpense_1_Q1_USD":32515000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":75980000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q1_USD":0.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_1_Q1_USD":6848000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":382005000.0,"OperatingLeasePayments_1_Q1_USD":9060000.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":7289000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":464572000.0,"AccountsPayableCurrent_0_Q1_USD":45381000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":237213000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-117041000.0,"ProceedsFromSaleOfRestrictedInvestments_1_Q1_USD":10650000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.01,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.01,"AccountsReceivableNet_0_Q1_USD":19111000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":13654000.0,"CommonStockSharesAuthorized_0_Q1_shares":250000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":177566000.0,"OperatingIncomeLoss_1_Q1_USD":-186254000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q1_USD":1273027000.0,"InventoryNet_0_Q1_USD":73940000.0,"InvestmentIncomeInterest_1_Q1_USD":450000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-4785660000.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":116340000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":3255269000.0,"PreferredStockSharesAuthorized_0_Q1_shares":5000000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":55690000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":38917000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-1.71,"OtherLiabilitiesNoncurrent_0_Q1_USD":60461000.0,"StockholdersEquity_0_Q1_USD":926190000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q1_USD":208123000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":17178000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":1272680000.0,"PreferredStockValue_0_Q1_USD":0.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":-27804000.0,"Ticker":"ALNY","CIK":"1178670","name":"ALNYLAM PHARMACEUTICALS, INC.","OfficialName":"Alnylam Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"19459816074.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210429"}]